CENTENE CORP (CNC) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of CENTENE CORP (CNC) from OUTPERFORM to NEUTRAL on November 21, 2013, with a target price of $68.90.

Centene Corporation provides managed care programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income, and the State Children's Health Insurance Program.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on CENTENE CORP (CNC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .